SCHEMBL23911547

SCHEMBL23911547

NC(=O)c1c[nH]c2nccc(-c3cc(Cl)cc4c3O[C@H](C(=O)N3CCNCC3)C4)c12

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP7 Q93009 13/20 0.70
MAP3K5 Q99683 1/20 0.34
ROCK1 Q13464 3/20 0.33
CDC42BPB Q9Y5S2 2/20 0.33
ROCK2 O75116 2/20 0.33
AKT1 P31749 2/20 0.33
MAP3K11 Q16584 1/20 0.33
CDC7 O00311 1/20 0.32
PLK4 O00444 1/20 0.32
CHEK1 O14757 1/20 0.32
MAPK13 O15264 1/20 0.32
PDPK1 O15530 1/20 0.32
DAPK3 O43293 1/20 0.32
DYRK3 O43781 1/20 0.32
PRKD3 O94806 1/20 0.32
MAP4K4 O95819 1/20 0.32
ABL1 P00519 1/20 0.32
PRKCG P05129 1/20 0.32
CDK1 P06493 1/20 0.32
ROS1 P08922 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23911614 1.00 USP7 (0.70) USP7MAP3K5ROCK1CDC42BPBROCK2
SCHEMBL23910788 1.00 USP7 (0.70) USP7MAP3K5ROCK1CDC42BPBROCK2
SCHEMBL23910990 0.88 USP7 (0.72) USP7ROCK1CDC42BPBROCK2AKT1
SCHEMBL23910986 0.88 USP7 (0.72) USP7ROCK1CDC42BPBROCK2AKT1
SCHEMBL23911491 0.88 USP7 (0.72) USP7ROCK1CDC42BPBROCK2AKT1
SCHEMBL23911576 0.88 USP7 (0.54) USP7CDK9
SCHEMBL23911529 0.82 USP7 (1.00) USP7ROCK1ROCK2CHEK1MKNK2
SCHEMBL23911108 0.82 USP7 (1.00) USP7ROCK1ROCK2CHEK1MKNK2
SCHEMBL23911361 0.82 USP7 (1.00) USP7ROCK1ROCK2CHEK1MKNK2
SCHEMBL23911519 0.81 USP7 (0.74) USP7JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317134-A1 UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 7 (USP7) MODULATORS AND USES THEREOF RAPT THERAPEUTICS INC (US) 2021-10-14 US disclosed
US-20210317134-A1 UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 7 (USP7) MODULATORS AND USES THEREOF RAPT THERAPEUTICS INC (US) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317134-A1 UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 7 (USP7) MODULATORS AND USES THEREOF USP7, SENP7, USP8 USP7 1/4885MAP3K5 1460/4885ROCK1 4356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.